$4.13
-0.17-3.85%
Last update: Aug 24, 10:25 AM
Ironwood Pharmaceuticals Inc Earnings Estimates
IRWDNASDAQ
Ironwood Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:IRWD
Ironwood Pharmaceuticals (IRWD) is scheduled to report Q3 earnings on November 9, 2026. Analysts estimate EPS of $0.31 and quarterly revenue of $127.1M.
In the most recent quarter (Q2), Ironwood Pharmaceuticals reported EPS of $0.31, beating estimates of $0.27 by 0.15%. Revenue came in at $113.04M, missing the estimate of $118.04M by 0.04%.
Ironwood Pharmaceuticals has beaten EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Ironwood Pharmaceuticals has averaged an EPS surprise of 0.87% and a revenue surprise of 0.25%.
Earnings Date
Nov 9
EPS Estimate
$0.310
Quarterly Revenue Estimate
$127.1M
Annual Revenue
$389.32M
as of Jun 30
Ironwood Pharmaceuticals Earnings History
Analyze the earnings history of Ironwood Pharmaceuticals using advanced sorting and filters.
Ironwood Pharmaceuticals (IRWD) Earnings Per Share
The chart below shows Ironwood Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
Ironwood Pharmaceuticals (IRWD) Revenue
The chart below shows Ironwood Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Ironwood Pharmaceuticals (NASDAQ:IRWD) reporting earnings?
Ironwood Pharmaceuticals (IRWD) is scheduled to report earnings on November 9, 2026. The last reported earnings were for reported on August 6, 2026 for Q2.
What were the latest earnings per share (EPS) for Ironwood Pharmaceuticals (NASDAQ:IRWD)?
The Actual EPS was $0.31, which beat the estimate of $0.27.
What were Ironwood Pharmaceuticals’s (NASDAQ:IRWD) revenues?
The Actual Revenue was $113.04M, which missed the estimate of $118.04M.
